« Previous | Next » | All Messages |  NGXL Message Board Home | recommend post |  Ignore Poster

NGXL News Nutralogix Labs Introduces New CEO Hired to Further Business Plan, Expanding Domestic and International Corporate Sales and Revenue

WESTON, Fla.--(BUSINESS WIRE)--Nutralogix Laboratories, Inc. (Pink Sheets:NGXL) (http://www.Nutralogixlabs.com) introduces its new CEO/President, Arne Rotne II, who brings vast executive and managerial business experience to the Company. Rotne was hired to take the Company’s Development and expansion to the next level based on years of experience in food, health, and other sectors, with long-term experience in hands-on product development, branding, marketing, and sales team management.

Rotne’s experience will allow him to guide Nutralogix smoothly through the second phase of its growth, which requires the years of expertise in allied fields necessary to expand the brand identity and further the sales and revenue. The new executive will focus substantially on the international development that has been initiated, permanently establishing offices abroad in Asia and Europe, along with warehousing and distribution centers.

“I welcome the challenge of building Nutralogix into a $20 million revenue company and believe that we can accomplish this based on the steps already taken and the business model that I intend to help the Company further develop and expand upon. We can take a significant market share of this sector and I believe that my experience in product development, branding, and marketing will serve this goal,” stated Rotne.

“We expect to soon announce additional concrete steps in our expansion, both here and abroad. I also believe that we have a number of opportunities to be ‘first in,’ product-wise in this sector, and we will aggressively pursue these goals, which should aid in increasing the name identification of Nutralogix, along with our revenue,” continued Rotne.

Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995: This release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements are presented based on current information available to management and in consideration of assumptions concerning information available to management regarding future events. Forward-looking statements are subject to risks and uncertainties that could cause future events or results to differ materially from such statements. Nutralogix Laboratories, Inc. disclaims any intent or obligation to update or revise any forward-looking statements and presents information herein solely for the intent of delivering general information regarding the company.